De la incertidumbre a las raíces: Joven padre logra hogar propio CIUDAD DE OKLAHOMA — Para Kevin S., ser propietario significa más que… Oklahoma City celebra un hito récord en el turismo impactando la economía OKLAHOMA CITY — El turismo en Oklahoma City alcanzó un nuevo hito,… LA VISIÓN GENERAL Por la líder demócrata del Senado, Julia Kirt El Capitolio estatal puede… El ABC de la seguridad en zonas escolares El ABC de la seguridad en zonas escolares El inicio de un… Brookside y Moore, entre las escuelas más estresantes de Oklahoma para padres Mientras las familias se preparan para el nuevo curso, los padres afrontan…

Lawmakers Request Interim Study on Opioid Prescriptions

Lawmakers Request Interim Study on Opioid Prescriptions

OKLAHOMA CITY – Rep. John Talley, R-Stillwater, has requested an interim study to investigate clinical outcomes of patients with pain following policies resulting in rapid reductions in opioid prescribing.

The study seeks to examine the effects of the restrictions on prescribed pain medication implemented within the state following the enactment of Senate Bill 1446 in Nov. 2018.

Talley said his goal is to bring together researchers, physicians, patients and policy analysts to hear multiple perspectives on the impacts of existing policies and if they have helped reduce opioid addiction in Oklahoma, as well as examine how these changes have affected patients and their ability to access the treatment they need.

“From the start, there should have been metrics in place to measure the clinical outcomes of patients impacted by laws enacted to address the opioids crisis,” Talley said. “It’s my hope that this study, if approved, will allow us to ensure these well-intentioned policies address the real issue while limiting unintended consequences.”

Talley is working with Rep. Ty Burns, R-Pawnee, and Rep. Preston Stinson, R-Edmond, to organize the study.

“This is a complex issue without a one size fits all solution,” Stinson said. “I look forward to hearing from all stakeholders to ensure that our laws are appropriate, safe, and adequate to address patients’ needs.”

The interim study request was filed under the number 21-105. The House Speaker will announce approved interim studies by Friday, July 23.

 

Comentar con Facebook

Comentar

Los campos obligatorios estan marcados con *

1 Comentarios

Noticias Relacionadas

Compartir